Brian Piekos

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Piekos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gemini Therapeutics, Inc. /DE CFO Common Stock 17,615 $1,191,655 $67.65 31 May 2022 Direct
KalVista Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Unit 60,000 $785,936 $9.82 21 Feb 2026 Direct
KalVista Pharmaceuticals, Inc. Chief Financial Officer Common Stock 13,762 $214,230 $15.57 23 Feb 2026 Direct
Elicio Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 43,225 01 Feb 2024 Direct

Insider Reports Filed by Brian Piekos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALV KalVista Pharmaceuticals, Inc. 21 Feb 2026 3 -$27,507 4 Chief Financial Officer 24 Feb 2026, 19:42
KALV KalVista Pharmaceuticals, Inc. 16 Jan 2026 1 $0 4 Chief Financial Officer 21 Jan 2026, 16:10
KALV KalVista Pharmaceuticals, Inc. 21 Nov 2025 3 -$60,139 4 Chief Financial Officer 26 Nov 2025, 18:50
KALV KalVista Pharmaceuticals, Inc. 21 Feb 2025 1 $0 4 Chief Financial Officer 25 Feb 2025, 20:35
KALV KalVista Pharmaceuticals, Inc. 09 Sep 2024 1 $0 4 Chief Financial Officer 11 Sep 2024, 16:34
KALV KalVista Pharmaceuticals, Inc. 09 Sep 2024 0 $0 3 Chief Financial Officer 11 Sep 2024, 16:32
ELTX Elicio Therapeutics, Inc. 01 Feb 2024 1 $0 4 Chief Financial Officer 05 Feb 2024, 06:01
ELTX Elicio Therapeutics, Inc. 01 Jun 2023 1 $0 4 Chief Financial Officer 05 Jun 2023, 17:25
ELTX Elicio Therapeutics, Inc. 01 Jun 2023 0 $0 3 Chief Financial Officer 05 Jun 2023, 17:08
IRON Gemini Therapeutics, Inc. /DE 31 May 2022 1 +$10,856 4 CFO 02 Jun 2022, 19:14
IRON Gemini Therapeutics, Inc. /DE 13 Jan 2022 1 $0 4 CFO 14 Jan 2022, 08:01
IRON Gemini Therapeutics, Inc. /DE 18 Oct 2021 1 $0 4 Chief Financial Officer 20 Oct 2021, 17:49
IRON Gemini Therapeutics, Inc. /DE 14 May 2021 1 +$72,432 4 Chief Financial Officer 18 May 2021, 16:45